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Background: Little is known about the prevalence of depression and anxiety among older people with
intellectual disabilities (ID). Therefore, the aim of this study was to study the prevalence of depression
and anxiety in this population.
Method: This study is a cross-sectional epidemiologic multicentre study which was part of the ‘‘Healthy
Ageing and Intellectual Disabilities’’ study. The study population consisted of 990 participants aged
Z50 years with borderline to profound ID which were screened with self-report and informant-report
instruments; 290 of them were assessed with a standardized diagnostic interview.
Results: Depressive symptoms were prevalent in 16.8% (95% CI: 14.4–19.1) and signiﬁcantly associated
with higher age. Anxiety symptoms were prevalent in 16.3% (95% CI: 14.0–18.6) and signiﬁcantly
associated with female gender and borderline to mild ID. Major depressive disorder was prevalent in
7.6% (95% CI: 5.2–11.0), anxiety disorders in 4.4% (95% CI: 2.6–7.0) and both in 0.7% (95% CI: 0.2–1.6).
There was no relationship with gender, age or level of ID.
Limitations: For most participants, informant-report instruments have been used instead of self-report
to overcome communication difﬁculties or inabilities. Also, a standardized psychiatric diagnostic
interview has been used instead of psychiatric diagnoses made by an experienced psychiatrist.
Conclusion: Prevalence of major depressive disorder is higher and of anxiety disorders lower than in the
Dutch general older community-dwelling population.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Background
In contrast to other research areas, comparatively little research
has focused on the prevalence of common Axis I psychiatric
disorders among older people with intellectual disabilities (ID). Life
expectancy of this population is increasing, implying a growing
number of older people with ID with age-related physical and
mental health problems (Woittiez and Crone, 2005; Perkins and
Moran, 2010). In the community-dwelling older population
(55þ years), depression and anxiety are common, with increased
depressive symptoms in 13.5–14.9%, increased anxiety symptoms in
14.9–18.5%, major depression in 1.8–4.0% and anxiety disorders in
10.2–11.6% (Beekman et al., 1995; Beekman et al., 1998, 1999;
Mehta et al., 2003; Byers et al., 2010). In smaller groups of older
people with ID (aged Z50 years), prevalence rates of 4.8–5.4% for
depression and 2.8–5.7% for anxiety disorders have been foundal Practice, Intellectual Dis-
er, P.O. Box 2040, 3000 CA
ermans).
sevier OA license.(Cooper, 1997; Patel et al., 1993; Reid et al., 2011). Results from the
general population cannot be directly translated to older people
with ID, because of substantial differences between both popula-
tions. In older people with ID, the prevalence of depression and
anxiety may be expected to be high, given their longstanding
disability, associated impairment and multiple co-morbid health
problems (Pope and Tarlov, 1991). On the other hand, group-home
living and higher psychotropic drug use may reduce depression and
anxiety (Stolker et al., 2002). In addition, people with ID may
present psychiatric symptoms differently and have limited or no
abilities to report symptoms (Einfeld and Tonge, 1999). These
diagnostic problems may limit the number of ICD-10 depression
and anxiety diagnoses in people with ID (Reid et al., 2011). Because
such diagnostic problems increase with severity of ID (Marston
et al., 1997), lower prevalence rates of psychiatric disorders, diag-
nosed according to standardized diagnostic criteria, are to be
expected in people with more severe ID.
The aims of this study were to examine prevalence rates of
increased depressive and anxiety symptoms, major depression,
and anxiety disorders in older adults with ID, as well as their
associations with gender, age and level of ID and compare the
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from the general Dutch older population.2. Method
2.1. Design and study population
This study was part of the cross-sectional ‘Healthy Ageing and
Intellectual Disabilities’ (HA-ID) study, performed in a consort of
three large formal ID services in the south–west of The Nether-
lands. These services provide care to a broad spectrum of clients,
covering different levels of support needs: centralized residential
accommodations, community-based homes, day activity centres
and supported independent living. The distribution of clients
primarily receiving care (35%) and clients primarily receiving
support (65%) is similar as in the total Dutch population using
formal ID services (Hilgenkamp et al., 2011). People with ID
unknown to formal ID-services are not part of our study
population.
For the HA-ID study, all clients aged 50 years or over were
invited to participate. The age-limit of 50 years was chosen,
because it is generally accepted, though not proven, that people
with ID, and not only people with Down syndrome, show signs of
premature ageing (Patel et al., 1993; Perkins and Moran, 2010). Of
the general Dutch population aged Z50 years, 0.5% is known to
formal ID services (Woittiez and Crone, 2005) of which 10%
receives care or support from one of the services participating
in this study. Recruitment and the informed consent-procedure
have been described in more detail elsewhere (Hilgenkamp et al.,
2011). In short, all clients receiving care or support on the 1st of
September 2008 have been invited to participate in the HA-ID
study. Except for ages Z50 years, no exclusion criteria have been
used. Of the total number invited, 49.7% of the clients or their
legal representatives gave informed consent to participate of
which 98.2% actually participated. Inclusion and participation of
the current study population are described in Fig. 1. This study
has been approved by the Medical Ethical Testing Committee of
the Erasmus University Medical Centre at Rotterdam, The Nether-
lands (MEC nr: 2008-234).2.2. Procedure
Because psychiatric diagnostic assessment of all participants is
too time consuming in large-scale epidemiologic research,
depression and anxiety disorders were diagnosed with a two-
step diagnostic procedure. To evaluate increased depressive and
anxiety symptoms, three self-report and two informant-report
screening instruments for depression and anxiety were selected
after a review of the literature, evaluation of psychometric
properties, and consultation of experts on applicability for large-
scale assessment of adults with ID. Participants who have border-
line, mild or moderate ID were considered capable of self-report if
they used comprehensible speech and could oversee the time-
frame of at least one week. Self-report instruments were applied
by eight trained interviewers. All interviewers had a background
in psychological testing and have been additionally trained in
applying the instruments used in this study. Informant-report
instruments were completed in writing by professional caregivers
who knew the participant for at least three months. Increased
depressive or anxiety symptoms were deﬁned as a score above
the cut-off of at least one depression or anxiety screening
instrument respectively. Cut-off scores were based on published
guidelines by the questionnaires’ developers or results of earlier
studies.All participants with at least one score above the cut-off of one
of the screening instruments were further examined with a
standardized psychiatric interview within two weeks. Because
published sensitivities of the screening questionnaires vary
between 71% and 84% and speciﬁcities between 52% and 78%,
and because at the start of the study, criterion validity for the
translated instruments still had to be evaluated by us, we also
performed the psychiatric interview in an additional random
sample of participants with scores below all cut-off scores. This
procedure made it necessary, to extrapolate the results of parti-
cipants assessed with the diagnostic interview to all other
participants, taking their screening results into account, in order
to estimate prevalence rates of major depression and anxiety
disorders. To illustrate this, the extrapolation procedure for major
depression is presented in Fig. 2. The 95% conﬁdence intervals of
the prevalence rates were calculated with a Bayesian method
(Lunn et al., 2000).
Gender, age, level of ID, mobility, genetic syndromes, autism
spectrum disorder and psychotropic medication use (Anatomical
Therapeutic Chemical (ATC) classiﬁcation: N05B and N06A) were
retrieved from the participants’ ﬁles. The ATC classiﬁcation system is
an international system of the WHO which classiﬁes drugs in groups
according to the organ or system on which they act and their
chemical, pharmacological and therapeutic properties (WHO
Collaborating Centre for Drug Statistics Methodology, 2011). Data
on psychotropic medication and genetic syndromes were obtained
through the participant’s physician and data on level of ID and
autism spectrum disorders through the participant’s psychologist or
behavioural therapist. In The Netherlands, level of ID is assessed with
IQ-testing, using varying tests according to the abilities of the person
with ID.
2.3. Measures
For depression, participants capable of self-report were screened
with the Inventory of Depressive Symptomatology Self Report (IDS-
SR) (Rush et al., 1986) and participants incapable of self-report
with the Dutch informant-report Signalizing Depression List for
people with Intellectual Disabilities (SDL-ID) (Roeden, 1989b).
The IDS-SR has been developed for the general population and we
adapted its phrasing for better applicability. In people with ID, its
internal consistency and test–retest reliability are good (a¼0.89
and ICC¼0.91) and the validity is satisfactory (sensitivity 71% and
speciﬁcity 54%) (Bassa, 2011). Its score ranges from 0 to 84. We
used a cut-off score of Z18 (Rush et al., 1996). The SDL-ID’s
internal consistency and interrater reliability in older people with
ID are good (a¼0.77 and r¼0.87) (Roeden, 1989a). The score on
the SDL-ID ranges from 18 to 72. We used a cut-off score of Z35
(Schoonhoven, 2001). In a pilot study, the IDS-SR and SDL-ID were
completed both for 23 participants, showing 100% correspon-
dence for the used cut-off scores.
For anxiety, all participants were screened with the Anxiety,
Depression, And Mood Scale (ADAMS) (Esbensen et al., 2003). The
ADAMS is an informant-report instrument, speciﬁcally developed for
adults with ID, consisting of ﬁve subscales developed for adults with
ID. The total ADAMS was completed, but the general anxiety subscale
was used for this study. This subscale’s internal consistency, test–
retest reliability and interrater reliability are good (a¼0.88, ICC¼0.86
and ICC¼0.74) and its validity is satisfactory (sensitivity 80–82% and
speciﬁcity 65–78%) in older people with ID (Hermans et al., 2012).
The score on the general anxiety subscale ranges from 0 to 21. We
used the cut-off scores recommended by Hermans et al. (2012): Z10
for participants without autism and Z14 for those with an autism-
spectrum disorder. Participants capable of self-report were also
screened with the Glasgow Anxiety Scale for people with an
Intellectual Disability (GAS-ID) (Mindham and Espie, 2003) and the
Fig. 1. Flow-chart inclusion of study population.
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A) (Zigmond and Snaith, 1983), in addition to the ADAMS. The GAS-ID
has been developed for people with ID and its internal consistency
and reliability are good (a¼0.86 and ICC¼0.89) and its validity is
sufﬁcient (sensitivity 84% and speciﬁcity 52%) (Mindham and Espie,
2003). Its score ranges from 0 to 54. We used a cut-off score of Z17
(Hermans et al., in press). The HADS-A has been developed for the
general population. Standardized explanatory information was added
to four items (2, 3, 6 and 7) for better comprehension. Psychometric
properties are fair to good in the general older population (Spinhoven
et al., 1997; Croon et al., 2005). Its score ranges from 0 to 21. We used
a cut-off score of Z8, as recommended for the Dutch population
(Croon et al., 2005).Psychiatric diagnoses were made using the Dutch version of the
Psychiatric Assessment Schedule for Adults with a Developmental
Disability (PAS-ADD) (Moss et al., 1994). The PAS-ADD is a semi-
structured, diagnostic interview which focuses on the more common
axis I disorders, and has been based on the Schedules for Clinical
Assessment in Neuropsychiatry (SCAN) (World Health Organization,
1992). Current diagnoses of Major Depressive Disorder (MDD),
general anxiety disorder, panic disorder, agoraphobia, social phobia
and speciﬁc phobia based on ICD-10 criteria (World Health
Organization, 1994) can be made with the PAS-ADD. Its psychometric
properties are satisfactory (Costello et al., 1997; Moss et al., 1997). It
has been validated in people with ID against expert psychiatric
diagnosis. The questions of the PAS-ADD interview can be answered
Fig. 2. Extrapolation procedure of major depressive disorder (MDD).
Table 1
Characteristics of the study population (n¼990).
Characteristic n % Median (IQR)
Gender
Male 508 51.3
Female 482 48.7
Age (yrs)
50–65 685 69.2
Z65 305 30.8
Level of ID
Borderline (IQ¼70–84) 31 3.1
Mild (IQ¼50–69) 211 21.3
Moderate (IQ¼35–49) 471 47.6
Severe (IQ¼20–34) 165 16.7
Profound (IQo20) 89 9.0
Unknown 23 2.3
Accommodation
Central locationa 536 54.1
Community home 403 40.7
Living with family 7 0.7
Independent living 44 4.4
AEtiology of IDb
None 617 62.3
Down syndrome 142 14.3
Other syndromes 67 6.8
Unknown 46 4.6
Psychotropic drug usec
Antidepressants 99 10.0
Anxiolytics 97 9.8
Screening questionnaires completed
SDL-ID 789 79.7 27.00 (9.00)
General anxiety (ADAMS ) 975 98.5 4.00 (6.00)
IDS-SR 215 21.7 7.00 (9.00)
GAS-ID 215 21.7 10.00 (8.00)
HADS-A 217 21.9 3.00 (4.00)
ADAMS, Anxiety, Depression, And Mood Scale; SDL-ID, Signalizing Depression List
for people with Intellectual Disabilities; IDS-SR, Inventory of Depressive Sympto-
matology Self Report; GAS-ID, Glasgow Anxiety Scale for people with an Intellec-
tual Disability; HADS-A, Anxiety subscale of the Hospital Anxiety and
Depression Scale
a Central location refers to accommodations in a sheltered environment with
surrounding health facilities (e.g., physician, dentist, movement therapy centre)
b 118 missing.
c 115 missing.
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applied by eighteen psychologists and behavioural therapists, experi-
enced in working with older people with ID, who were additionally
trained in recognizing psychiatric disorders and the interview’s
system. These interviewers were blind for the result of the screening
and had no prior knowledge of the participants, except for some
exceptional cases in which the interviewer was involved in the
participant’s usual care. The PAS-ADD interview does not include a
differential diagnosis of dementia, but all trained psychologists and
behavioural therapists were instructed to score ‘uncertain’ if a
symptom was impossible to score due to confounding factors, such
as dementia. Items have only been scored as ‘uncertain’ if there were
considerable doubts of the justiﬁability to score the symptom as
present even after extensive exploration of the symptom. ‘Uncertain’
symptoms were excluded from the ﬁnal diagnostic decision.
2.4. Statistical procedure
All analyses were done with the Statistical Package for the
Social Sciences 17.0. First, non-response analyses were done using
a t-test for age and X2-tests for gender and residential setting.
To enable comparison with other studies, point prevalence
rates of increased depressive and anxiety symptoms, major
depression and anxiety disorders were calculated for the total
study population, as well as for subgroups aged 55 years or over,
aged from 50 to 65 years, and participants aged 65 years or over.
Prevalence rates will be presented with 95% conﬁdence intervals.
The prevalence rates of major depression and anxiety disorders
were compared to ﬁndings of the Longitudinal Aging Study
Amsterdam in the general Dutch older population, aged 55–85
years, by calculating Standardized Morbidity Ratios (SMR) taking
age and gender distribution into account (Liddell, 1984). SMR is a
ratio between the observed and expected numbers of individuals
with poor health. An SMR (observed/expected) of 1 means similar
prevalence rates.
Logistic regression analyses were used to study the association
between gender, age, level of ID (borderline/mild, moderate, severe/
profound) and Down syndrome (independent variables) and
increased depressive symptoms, increased anxiety symptoms,
MDD and anxiety disorders (dependent variables). All independent
variables were simultaneously entered into the regression to control
for their inﬂuence on other independent variables in the regression.
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therefore dummy variables were constructed for the level of ID.
Participants with a diagnosis of dementia, made by both their
physician and their psychologist or behavioural therapist, were
excluded from the regression analysis with increased depressive
symptoms (n¼41), because of the resemblances of depression and
dementia symptoms and the high prevalence of dementia in Down
syndrome. The magnitude of association of the independent vari-
ables with increased depressive and anxiety symptoms and dis-
orders were compared by calculating odd’s ratios. Multicollinearity
refers to a high correlation between independent variables, which is
not preferred in regression analysis, and was checked for all
independent variables with the variance inﬂation factor (VIF) of
linear regression analysis (Craney and Surles, 2007). The proportion
of the dependent variable which is explained by the factors in the
model was calculated with R2 of Hosmer and Lemeshow (1989).3. Results
The screening questionnaires were completed for 990 partici-
pants (Fig. 1) with a mean age of 61.1 years (S.D.¼8.2). Non-
participants (n¼1332) and participants were not signiﬁcantly
different for age (t¼0.27, p¼0.79), but men (X2¼4.72, po0.05)
and people living independently (X2¼44.22, po0.05) were
slightly underrepresented in the sample. The diagnostic interview
was applied to 199 participants with at least one score above the
cut-off and 91 participants with low screening scores (Fig. 1).
These 290 participants did not signiﬁcantly differ on age, gender
or level of ID from the other participants with screening scoresTable 2
Prevalence rates (95% CI) of increased depressive and anxiety symptoms and disorders
Age groups
Z50 years
n (n with diagnostic interview) 990 (290)
Symptoms
Depressive symptoms 16.8% (14.4–19.1)
Anxiety symptoms 16.3% (14.0–18.6)
Co-occurring depressive and anxiety symptoms 7.7% (6.1–9.5)
Disorders
Depression (MDD)a 7.6% (5.2–11.0)
Anxiety disorders 4.4% (2.6–7.0)
Co-occurring MDD and anxiety disorders 0.8% (0.3–1.5)
a MDD¼major depressive disorder.
Table 3
Results of the logistic regression analyses with depression and anxiety for the total po
Increased depressive
symptoms
n 820
Model ﬁt
Chi-square 12.66n
Degrees of freedom 5
R2 1.8%
Odds ratios (95% CI) of independent variables
Female 0.98 (0.67–1.44)
Age in years 1.04n (1.02–1.06)
Borderline/mild ID (versus moderate-profound ID) 0.66 (0.38–1.17)
Moderate ID (versus borderline-profound ID) 0.87 (0.56–1.37)
Down syndrome 1.10 (0.60–2.00)
n po0.05.
nn po0.01.above or below the cut-off (data not shown). Time between
screening and diagnostic interview was four weeks on average.
Characteristics of the study population are described in Table 1. In
the regression analyses, there was no multicollinearity; VIFs were
between 1.01 and 1.79.
3.1. Increased depressive and anxiety symptoms
The prevalence rates of increased depressive and increased
anxiety symptoms are presented in Table 2. Higher age was
signiﬁcantly associated with depressive symptoms and border-
line/mild ID with anxiety symptoms (Table 3).
3.2. Major depressive disorder (MDD) and anxiety disorder
The point prevalence of MDD was 7.6% and anxiety disorders
4.4% (Table 2). For the total population, the prevalence rates of the
speciﬁc anxiety disorders were generalized anxiety disorder
(GAD): 0.5% (CI: 0.2–1.1), phobia: 3.3% (CI: 1.8–5.7) and panic
disorder: 1.8% (CI: 0.7–3.6). Age, gender, level of ID and Down
syndrome were not signiﬁcantly associated with depression or
anxiety disorders (Table 3). Compared to the Dutch general older
community-dwelling population (Table 4), the SMR of MDD was
5.15 (CI: 3.93–6.63) and of anxiety disorders 0.59 (CI: 0.42–0.80).
MDD, as diagnosed during the study, had also been reported
by the participant’s psychologist or behavioural therapist in 37.5%
and anxiety disorder in 26.3%. Comparison with drug treatment
was not possible, because prescription indications have not been
scored, whereas psychotropic drugs can be prescribed for differ-
ent indications, including epilepsy and challenging behaviour..
Z55 years 50–65 years Z65 years
732 (221) 685 (183) 305 (107)
17.4% (14.7–20.3) 15.5% (12.8–18.4) 19.7% (15.4–24.6)
16.5% (13.9–19.4) 15.6% (13.0–18.6) 17.7% (13.6–22.5)
8.1% (6.2–10.3) 7.5% (5.6–9.7) 8.2% (5.4–11.9)
8.1% (5.2–12.0) 7.5% (4.3–11.8) 8.9% (4.5–13.7)
5.2% (2.9–8.5) 3.8% (1.8–6.8) 5.6% (2.6–10.8)
0.8% (0.3–1.9) 0.7% (0.2–1.7) 1.0% (0.1–2.4)
pulation.
Increased anxiety
symptoms
Major depressive
disorder
Anxiety disorders
862 241 241
39.01nn 6.27 5.61
5 5 5
5.2% 3.3% 4.4%
1.46 (0.99–2.14) 0.79 (0.52–2.34) 1.84 (0.66–5.16)
1.00 (0.98–1.02) 1.02 (0.97–1.07) 1.01 (0.95–1.07)
3.73nn (2.14–6.52) 0.54 (0.17–1.67) 1.45 (0.41–5.19)
1.62 (0.95–2.76) 1.16 (0.45–3.01) 0.47 (0.12–1.86)
0.59 (0.31–1.13) 0.33 (0.07–1.53) 1.02 (0.20–5.24)
Table 4
Comparison with the Dutch older general community-dwelling population.
55–64 years 65–74 years 75–85 years
Male Female All Male Female All Male Female All
LASAa n 465 499 964 442 512 954 571 567 1138
Major depression (%) 1.1 1.6 1.6 0.9 2.9 2.0 2.1 3.2 2.6
Anxiety disorders (%) 4.2 9.1 6.9 10.3 16.6 13.9 7.4 13.7 10.4
HA-IDb n 237 208 445 111 104 215 30 35 65
Major depression (%) 10.6 5.8 8.3 7.2 5.8 6.5 10.0 17.1 13.8
Anxiety disorders (%) 6.3 3.4 4.9 5.4 6.7 6.0 3.3 5.7 4.6
a LASA¼Longitudinal Aging Study Amsterdam, data retrieved from Beekman et al. (1995, 1998).
b HA-ID¼Health Ageing and Intellectual Disability.
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This is the ﬁrst large-scale study into increased depressive and
anxiety symptoms and diagnoses of major depressive disorder
and anxiety disorders among older people with ID, showing
prevalence rates of 17% for increased depressive symptoms, 16%
for increased anxiety symptoms, 8% for major depressive disorder
(MDD), 4% for total anxiety disorders and 1% for co-morbid
depression and anxiety disorders. The prevalence of MDD is
higher than that in the Dutch general older population (SMR
5.15), but the prevalence of anxiety disorders is lower (SMR 0.59).
Symptoms as well as disorders seem to increase with age, but this
is only signiﬁcant for depressive symptoms, whereas increased
anxiety symptoms are associated with borderline or mild ID. A
majority of depression and anxiety disorders were unknown to
the participants’ psychologists or behavioural therapists.
Both depression and anxiety disorders have been studied in
smaller samples of older people with ID. Reid et al. (2011) studied
anxiety in 364 adults aged Z50 years using the Present Psychiatric
State for Adults with Learning Disabilities. The prevalence of anxiety
disorders was 2.7% (CI: 1.5–5.0), which is similar to our ﬁndings.
Cooper (1997) studied 134 adults aged Z65 years, also with the
Present Psychiatric State for Adults with Learning Disabilities, and
found that depression was prevalent in 6.0% (CI: 3.1–11.3), which is
similar to our ﬁndings, and generalized anxiety disorder (GAD) in
9.0% (CI: 5.2–15.0), which is much higher than our 0.5% prevalence.
Patel et al. (1993) studied 105 adults aged Z50 years using the PAS-
ADD and found that depression was prevalent in 4.8% (CI: 2.1–10.7),
overlapping our study ﬁndings, and anxiety disorders in 5.7% (CI:
2.6–11.9), which also overlaps our 4% prevalence. The differences in
used diagnostic instruments and characteristics of the study popula-
tions require cautious comparison, but it seems that our prevalence
rates of major depression and anxiety disorders are similar to those
found in earlier studies, except for GAD, which is less prevalent in
our study.
As described in the introduction, we had expected to ﬁnd
higher levels of depression and anxiety among older people with
ID than those found in the general population. Considering major
depressive disorder, this was indeed what we found (Beekman
et al., 1995). The prevalence is almost comparable to that in the
general nursing-home population aged Z55 years (Jongenelis
et al., 2004) which is a frail population with considerable health
problems. This may imply an increased vulnerability of older
people with ID. For anxiety disorders, we found lower prevalence
rates while the prevalence of increased anxiety symptoms
appears similar (Beekman et al., 1998). Remarkably, this trend
has also been found in nursing-home residents (Smalbrugge et al.,
2005). Smalbrugge et al. (2005) speculated that this may have
been caused by speciﬁc characteristics of the nursing-home
environment, such as a ﬁxed daily routine and professional care,
which is also applicable to most people with ID receiving care orsupport from formal services. Moreover, professional caregivers
in ID services are specialized in limiting stressful situations and
the availability of support or care may in itself decrease anxiety as
well. The lower prevalence could also be explained by the high
psychotropic and anti-epileptic drug use by people with ID
(Stolker et al., 2002; Espie et al., 2003), because these drugs
may have a calming effect. A ﬁnal explanation could be that
recognition of physical or cognitive symptoms of anxiety (e.g.,
pounding heart, worrying, etc.) by informants may be difﬁcult and
therefore limited, while such symptoms are characteristic for
anxiety disorders. This could also explain the higher prevalence of
increased anxiety symptoms in people with borderline or mild ID,
who are more often capable of self-report. Their comparatively
low need of professional support and higher community partici-
pation may lead to more exposure to stressful conditions and
increase anxiety (Dusseljee et al., 2011).
The low recognition of depression and anxiety in clinical
practice is a cause of concern. A low detection rate implies almost
certainly also a low treatment rate. Therefore, pro-active detec-
tion and intervention should be stimulated by the provision of
well-evaluated screening instruments and training of profes-
sionals. Professionals working in clinical practice should realize
that increased depressive and anxiety symptoms require atten-
tion too, because they are common in older people with ID and
may be a sign of clinically relevant conditions, which can be
relieved with treatment.
Although the diagnostic procedure of this study was carefully
prepared, it still had some limitations, connected with the large
scale of the study on one hand, and with problems that are typical
of research in the ID ﬁeld, on the other. We had to partially rely on
screening to limit the number of complete psychiatric interviews,
which made extrapolation inevitable. Moreover, the PAS-ADD
interview does not include all psychiatric diagnoses (e.g., obses-
sive-compulsive disorder) and is based on standard diagnostic
criteria for depression and anxiety, while adapted diagnostic
criteria may be more suitable to detect psychiatric disorders in
people with ID (Reid et al., 2011). Furthermore, minor depression
could not be diagnosed, because depressive symptoms were only
asked for a preceding period of four weeks. Clinical tasks of locally
trained diagnosticians competing with research tasks prolonged
the aimed period of two weeks between screening and diagnostic
interview, which may have caused a discrepancy because of the
natural course of depression and anxiety. Typical for this ﬁeld is
the necessity of reliance on informant-report for most partici-
pants, as is the reliance on legal representatives for informed
consent, resulting in a relatively low response rate for this
extensive health study, in spite of a thorough communication
procedure. Despite the low response rate, the study population
was an almost representative sample of the entire population
of Z50 years receiving care or support from formal Dutch
intellectual disability services. Men and people living independently
H. Hermans et al. / Journal of Affective Disorders 144 (2013) 94–100100were slightly underrepresented. It seems that the results are still
generalizable to the total population known to ID services, because
both characteristics were not related to depression and anxiety.
Nevertheless, living situation may be partly related to level of ID
and this is associated with increased anxiety symptoms. However,
we were not able to compare the level of ID of non-participants
with those of participants, because this information was unknown
for non-participants.
Nevertheless, it is important to realize, that these limitations
may have resulted into an underestimation rather than an over-
estimation of the prevalence rates. In conclusion, this epidemio-
logic study led to relevant insights into prevalence of mental
health problems of older people with ID.Role of funding source
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